Brief: Medrx signs technology license agreement with Takeda
27/08/2018 02:40
Aug 27(Reuters) - Medrx Co Ltd 4586.T
* Says it signed a technology license agreement with Takeda
Pharmaceutical Co Ltd 4502.T , to support the development of
selected Takeda pipeline compounds in a focused therapeutic area
with its proprietary technology for transdermal drug delivery,
on Aug. 24
Source text in Japanese:https://goo.gl/UBRtDs
Further company coverage: 4586.T 4502.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724;
Reuters Messaging: huafang.zhang.reuters.com@reuters.net))